Provided by Tiger Trade Technology Pte. Ltd.

John Hancock Premium Dividend Fund

12.54
-0.0600-0.48%
Post-market: 12.540.00000.00%19:30 EDT
Volume:104.33K
Turnover:1.31M
Market Cap:616.78M
PE:4.91
High:12.70
Open:12.58
Low:12.53
Close:12.60
52wk High:13.65
52wk Low:12.49
Shares:49.19M
Float Shares:49.19M
Volume Ratio:1.34
T/O Rate:0.21%
Dividend:1.02
Dividend Rate:8.14%
EPS(TTM):2.55
EPS(LYR):1.39
ROE:18.06%
ROA:2.88%
PB:0.84
PE(LYR):9.01

Loading ...

Press Release: JOHN HANCOCK CLOSED-END FUNDS RELEASE EARNINGS DATA

Dow Jones
·
May 20

Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update

GlobeNewswire
·
May 14

Press Release: LogicMark, Inc. Announces Strong First Quarter 2026 Results

Dow Jones
·
May 14

Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis

GlobeNewswire
·
May 13

Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026

GlobeNewswire
·
May 09

John Hancock Premium Dividend Fund director Christine Hurtsellers acquires USD 11,989 shares

Reuters
·
May 08

Press Release: Logitech Announces Q4 and Full Fiscal Year 2026 Results

Dow Jones
·
May 06

Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026

GlobeNewswire
·
May 05

WidePoint to Present at the LD Micro Invitational XVI on Monday, May 18, 2026 at 10:30 a.m. PDT

GlobeNewswire
·
May 05

Press Release: JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS

Dow Jones
·
May 02

John Hancock Premium Dividend Fund pays monthly distribution of $0.0825 a share

Reuters
·
May 01

Press Release: Logitech Announces Date for Release of Fourth Quarter and Full-Year Financial Results for FY 2026

Dow Jones
·
Apr 08

Press Release: JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS

Dow Jones
·
Apr 02

John Hancock Premium Dividend Fund declares $0.0825 monthly distribution per share

Reuters
·
Apr 01

Biofrontera Inc. Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update

GlobeNewswire
·
Mar 19

Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026

GlobeNewswire
·
Mar 10

Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz® Photodynamic Therapy for moderate to severe Acne Vulgaris

GlobeNewswire
·
Mar 09